Sisram Medical (1696.HK) Stock Price
Sisram Medical Price
Over the last 10 years Sisram Medical grew revenue by 13.2% annually, reaching 349.11 M USD. Earnings per share have grown at 12.3% per year over the last 10 years. For Sisram Medical, the net margin of 7.2% is down versus 8.2% a few years ago. The payout ratio is around 38% of earnings. The dividend has grown at 9.6% per year over the past 5 years. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Sisram Medical stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Sisram Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sisram Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sisram Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Sisram Medical Price |
|---|
Sisram Medical Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Sisram Medical Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101.00 | 110.00 | 118.00 | 136.00 | 153.00 | 173.00 | 162.00 | 294.00 | 354.00 | 359.00 | 349.00 | 373.00 | 407.00 | 446.00 | 484.00 |
| – | 8.91 | 7.27 | 15.25 | 12.50 | 13.07 | -6.36 | 81.48 | 20.41 | 1.41 | -2.79 | 6.88 | 9.12 | 9.58 | 8.52 |
| 50.50 | 51.82 | 52.54 | 53.68 | 53.59 | 54.91 | 55.56 | 56.46 | 57.06 | 61.00 | 61.89 | 61.89 | 61.89 | 61.89 | 61.89 |
| 51.00 | 57.00 | 62.00 | 73.00 | 82.00 | 95.00 | 90.00 | 166.00 | 202.00 | 219.00 | 216.00 | 230.85 | 251.90 | 276.03 | 299.55 |
| 16.00 | 17.00 | 18.00 | 19.00 | 21.00 | 23.00 | 16.00 | 42.00 | 46.00 | 39.00 | 28.00 | 40.00 | 44.00 | 48.00 | 52.00 |
| 15.84 | 15.45 | 15.25 | 13.97 | 13.73 | 13.29 | 9.88 | 14.29 | 12.99 | 10.86 | 8.02 | 10.72 | 10.81 | 10.76 | 10.74 |
| 5.00 | 7.00 | 8.00 | 11.00 | 21.00 | 20.00 | 13.00 | 31.00 | 40.00 | 31.00 | 25.00 | 40.00 | 39.00 | 47.00 | 57.00 |
| – | 40.00 | 14.29 | 37.50 | 90.91 | -4.76 | -35.00 | 138.46 | 29.03 | -22.50 | -19.35 | 60.00 | -2.50 | 20.51 | 21.28 |
| – | – | – | – | – | 0.10 | 0.11 | 0.07 | 0.16 | 0.17 | 0.16 | 0.13 | 0.13 | 0.13 | – |
| – | – | – | – | – | – | 10.00 | -36.36 | 128.57 | 6.25 | -5.88 | -18.75 | – | – | – |
| 352.00 | 352.00 | 352.00 | 284.69 | 442.16 | 442.16 | 442.16 | 452.87 | 466.77 | 468.34 | 468.34 | 468.34 | 468.34 | 468.34 | 468.34 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Sisram Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sisram Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sisram Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Sisram Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sisram Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Sisram Medical stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Sisram Medical Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Sisram Medical business model & stock analysis
Sisram Medical SWOT Analysis
Strengths
Sisram Medical Ltd has several strengths that contribute to its success:
- Strong brand reputation in the medical industry.
- Wide range of innovative medical devices and solutions.
- Strong network of strategic partnerships with healthcare providers.
- Well-established global distribution channels.
- Experienced and knowledgeable management team.
Weaknesses
Although Sisram Medical Ltd has various strengths, it also faces certain weaknesses:
- Relatively high production costs affecting profit margins.
- Limited market penetration in certain geographical regions.
- Dependency on a few key suppliers.
- Requires continuous investment in research and development.
- Vulnerability to changes in healthcare regulations.
Opportunities
Sisram Medical Ltd can capitalize on the following opportunities:
- Increasing demand for advanced medical technologies worldwide.
- Expansion into emerging markets with growing healthcare sectors.
- Acquisition or partnership opportunities to enhance product portfolio.
- Growing trend towards non-invasive and minimally invasive procedures.
- Potential for introducing new products to address unmet medical needs.
Threats
Sisram Medical Ltd faces certain threats that may impact its growth and profitability:
- Intense competition from existing and new players in the medical device market.
- Economic downturns affecting healthcare spending and demand.
- Stringent regulations and compliance requirements.
- Rapid technological advancements leading to product obsolescence.
- Currency fluctuations affecting international operations.
Sisram Medical Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Sisram Medical historical P/E ratio, EBIT multiple, and P/S ratio
Sisram Medical annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Sisram Medical shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Sisram Medical Dividend History
7 years of dividend payments
Sisram Medical dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Sisram Medical dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Sisram Medical forecasts and price targets in August 2026
Analyst Price Targets 2026Sisram Medical shareholder structure
| % | Name |
|---|---|
0.31951% | |
0.01992% | |
0.01144% |
Sisram Medical Beneficial Ownership Filings (SEC 13D/G)
Sisram Medical Executives and Management Board
10 members · avg. age 48 · 30 % women
Mr. Lior Moshe Dayan (52)
Chief Executive Officer, Executive Director · since 2017
1.59 M USD
Management
Mr. Li Jiahong (46)
Chief Financial Officer, Executive Director · since 2024
Ms. Qianli Fang (28)
Company Secretary
Board of Directors
Mr. Chi Fung Chan (45)
Non-Executive Independent Director
Ms. Jenny Chen (44)
Non-Executive Independent Director
Mr. Heung Sang Fong (65)
Non-Executive Independent Director
Mr. Kai Yu Liu (54)
Non-Executive Independent Director
Mr. Yi Liu (49)
Executive Chairman of the Board · since 2016
Ms. Rongli Feng (45)
Non-Executive Director
Frequently asked questions about Sisram Medical
Sisram Medical Ltd operates through a business model focused on the development, manufacturing, and distribution of energy-based aesthetic medical and cosmetic devices. As a leading global provider, Sisram Medical offers a wide range of products designed to enhance procedures like hair removal, wrinkle reduction, body contouring, and skin rejuvenation. By leveraging their expertise in advanced technologies and medical aesthetics, Sisram Medical aims to cater to the growing demand for non-invasive and minimally invasive aesthetic procedures. With a strong commitment to innovation and customer satisfaction, Sisram Medical Ltd continues to strive in the aesthetic medical industry.
Sisram Medical Ltd is primarily active in the healthcare and medical device industries.
The main competitors of Sisram Medical Ltd in the market include leading players in the medical aesthetics industry such as Syneron Medical Ltd and Cutera Inc. These companies also specialize in providing a wide range of innovative and advanced aesthetic medical devices and solutions. However, Sisram Medical Ltd sets itself apart through its unique offerings and cutting-edge technologies that cater to the specific needs of its customers. With its strong market presence and commitment to excellence, Sisram Medical Ltd continues to establish itself as a formidable competitor in the medical aesthetics market.
Sisram Medical Ltd is a leading global provider of energy-based aesthetic medical and minimally invasive surgical devices. Founded in 2000, the company has established a strong presence in the medical aesthetics market. Sisram Medical offers a wide range of innovative products and solutions designed to enhance beauty, improve health, and promote well-being. With a strong focus on research and development, Sisram Medical continuously strives to deliver cutting-edge technologies and advanced treatment options to its customers. The company has achieved significant growth and success over the years, and its commitment to excellence has made it a trusted name in the medical aesthetics industry.
Sisram Medical Ltd has achieved several significant milestones in its journey. The company has successfully established itself as a global leader in the field of medical aesthetics and energy-based devices. Sisram Medical Ltd has continuously advanced its product portfolio, introducing innovative technologies and solutions for various medical and cosmetic procedures. With a strong focus on research and development, the company has received numerous accolades for its breakthrough products and cutting-edge technologies. Sisram Medical Ltd has also expanded its global presence, establishing strategic partnerships and collaborations to strengthen its market position. Overall, Sisram Medical Ltd has an impressive track record of achievements, cementing its reputation as a trusted and progressive player in the healthcare industry.
Sisram Medical Ltd is primarily present in multiple countries and regions worldwide. The company has a strong global presence and operates in various markets, including the United States, China, Europe, and Asia-Pacific. With its commitment to innovation and advanced medical technologies, Sisram Medical Ltd has successfully established a widespread presence in key healthcare markets around the globe.
Sisram Medical Ltd represents values of innovation, integrity, and excellence in the medical industry. As a leading global provider of comprehensive medical aesthetic solutions, the company is committed to enhancing people's lives through advanced technologies and high-quality products. Sisram Medical Ltd prioritizes customer satisfaction and remains dedicated to delivering state-of-the-art solutions while upholding the highest ethical standards. With a strong focus on research and development, Sisram Medical Ltd continuously strives to pioneer advancements in medical aesthetics, ultimately leading to improved patient outcomes and increased market value.
7 analysts currently rate the Sisram Medical stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sisram Medical to generate revenue of 407.47 M USD and earnings per share of 0.08 USD.
Sisram Medical is an international provider of high-tech medical technology, offering a wide range of innovative high-end products for use in aesthetic medicine and ophthalmic surgery. The company operates in three different business areas: aesthetic medicine, ophthalmology, and products for medical facilities. In the field of aesthetic medicine, the company offers various treatment options, including laser hair removal devices, ultrasound focus devices, and non-invasive skin tightening devices, among others. Sisram Medical is a joint venture between Chinese company Fosun Pharma and Israeli company Syneron Candela, founded in 2017. The company is headquartered in Yokneam, Israel, and has a presence in Europe, Asia, and the USA. In the field of ophthalmology, Sisram Medical offers lasers and accessories for various applications, including LASIK eye surgery and photodynamic therapy. The company also offers products for medical facilities with different focuses, such as patient monitoring systems, infusion systems, or medical sterilization devices. Sisram Medical aims to supply the market with innovative technologies and highest quality products. The company has established itself in the market primarily through its high innovation power and close collaboration with medical research institutions. Over the past years, Sisram Medical has successfully acquired numerous medium-sized companies in Europe and Asia to strengthen its presence in these markets. In the USA, the company is now one of the leading providers of medical laser devices. The company has further plans for the coming months and years to expand and deepen its business. Vertical integration and driving its own research and development projects are expected to play a central role. In terms of SEO optimization, for example, the names of the various laser devices or treatment options could be linked in the text to achieve better Google rankings. In summary, Sisram Medical Ltd offers a wide range of innovative medical technology products for use in the fields of aesthetic medicine, ophthalmology, and medical facilities. The company has many years of experience in the industry and a broad customer base. In the future, the focus will be on vertical integration and in-house research and development to establish itself as a market leader through even more innovative products.
The expected revenue of Sisram Medical is 407.47 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sisram Medical is 39.46 M USD. The net profit reflects the company's profitability after deducting all expenses.
The P/E ratio cannot be calculated for Sisram Medical at the moment.
The P/S cannot be calculated for Sisram Medical currently.
The Eulerpool Quality Score for Sisram Medical is 6/10.
The ISIN of Sisram Medical is IL0011418113. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sisram Medical is 1696.HK. The ticker symbol is used to trade Sisram Medical shares on the stock exchange.
The current dividend yield of Sisram Medical is - %.
Sisram Medical is assigned to the 'Health' sector.
The dividends of Sisram Medical are distributed in USD.
Sisram Medical stock
Sisram Medical Peer Group
Sisram Medical Ticker
Sisram Medical FIGI
All fundamentals and in-depth analysis of Sisram Medical
Our stock analysis for Sisram Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sisram Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.